Baystate Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$35.5K Buy
75
+1
+1% +$462 ﹤0.01% 440
2023
Q3
$32.6K Hold
74
﹤0.01% 398
2023
Q2
$33.2K Hold
74
﹤0.01% 389
2023
Q1
$34.2K Hold
74
﹤0.01% 386
2022
Q4
$38K Hold
74
﹤0.01% 372
2022
Q3
$34K Buy
74
+1
+1% +$478 ﹤0.01% 360
2022
Q2
$36K Hold
73
﹤0.01% 362
2022
Q1
$36K Hold
73
﹤0.01% 371
2021
Q4
$34K Hold
73
﹤0.01% 381
2021
Q3
$27K Buy
73
+22
+43% +$8.36K ﹤0.01% 376
2021
Q2
$19K Buy
51
+1
+2% +$382 ﹤0.01% 415
2021
Q1
$18K Buy
50
+30
+150% +$9.65K ﹤0.01% 389
2020
Q4
$7K Sell
20
-1
-5% -$307 ﹤0.01% 459
2020
Q3
$6K Buy
21
+1
+5% +$269 ﹤0.01% 447
2020
Q2
$5K Hold
20
﹤0.01% 458
2020
Q1
$5K Hold
20
﹤0.01% 426
2019
Q4
$6K Hold
20
﹤0.01% 437
2019
Q3
$5K Hold
20
﹤0.01% 414
2019
Q2
$6K Hold
20
﹤0.01% 407
2019
Q1
$5K Hold
20
﹤0.01% 433
2018
Q4
$5K Hold
20
﹤0.01% 437
2018
Q3
$5K Hold
20
﹤0.01% 437
2018
Q2
$5K Hold
20
﹤0.01% 447
2018
Q1
$5K Hold
20
﹤0.01% 421
2017
Q4
$5K Hold
20
﹤0.01% 430
2017
Q3
$4K Hold
20
﹤0.01% 431
2017
Q2
$4K Hold
20
﹤0.01% 431
2017
Q1
$3K Buy
+20
New +$3.18K ﹤0.01% 425

Other funds holding ELV

Baystate Wealth Management's ELV Position: Q4 2023 in Review

Baystate Wealth Management increased its Elevance Health (ELV) stake by 1.4% in Q4 2023, buying an estimated $462 and bringing the position to 75 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #440.

Baystate Wealth Management first reported a position in ELV in Q1 2017 and has held it in 28 quarters since. The position peaked at $38K in Q4 2022. 1,658 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Baystate Wealth Management held 75 shares of Elevance Health worth $35.5K as of Q4 2023.
  • Baystate Wealth Management bought 1 Elevance Health share in Q4 2023, an estimated $462.
  • Elevance Health made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #440 holding.
  • Baystate Wealth Management first reported a position in Elevance Health in Q1 2017 and has held it in 28 quarters since.
  • Baystate Wealth Management's Elevance Health position peaked at $38K in Q4 2022.
  • 1,658 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.